INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Mastering The Complexities Of Gene Therapy Document Writing
Gain the insight and strategic flexibility needed to confidently navigate the unique scientific, regulatory, and documentation challenges of gene therapy development.
-
Fixing The Monitoring Model: Flexible Resources For Trial Success
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
-
Two Views Of Risk When Choosing An IRT/RTSM Software Partner
In this clip, Ryan Keane of Korio explains why legacy RTSM vendors, designed for large pharmaceutical companies, often struggle to serve smaller, fast-moving Sponsors.
-
GLP Compliance In A Modern Lab: What Compliant Actually Requires In 2025
GLP compliance isn’t binary. Real defensibility depends on rigorous QA, validated electronic systems, and operational maturity — not just a label.
-
At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense12/23/2025
At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.
-
Key Strategies For Clinical Development In Rare Cancers2/11/2025
Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.
-
Breaking Silos In Drug Development: The Power Of An Integrated Model5/11/2026
Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.
-
How To Unlock The Secret To Repeatable, Scalable Low Turnover6/7/2024
Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.
-
Early Engagement With Sites: Timing Matters More Than Tools3/20/2026
Involving sites earlier in study planning changes how trials unfold. This piece explores how timing influences alignment, execution, and day-to-day delivery across the clinical research lifecycle.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Streamline trial budgets and payments with real-time fair market data, speeding startups and ensuring timely, transparent site funding worldwide.
-
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
-
Specialized, demand-driven resourcing from Veristat ensures a clinical team’s focus remains where it should be: meeting study milestones and accelerating time to market.
-
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.
Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.
-
Discover a debit card designed for clinical trials, providing participants with fast, reliable payments and giving sites and sponsors clear systems that help minimize burden and improve retention.